Last Friday, pharmaceutical giant Gilead Sciences shared more good news about the effectiveness of its COVID-19 treatment drug remdesivir. According to new clinical trial results published on Friday, the drug maker says new analysis of its antiviral drug remdesivir suggests a 62% cut […]